Visualization of Receptor-Interacting Protein Kinase 1 (RIPK1) by Brain Imaging with Positron Emission Tomography

Area of Science:

• Neuroscience
• Radiochemistry
• Molecular Imaging

Background:

• Receptor-Interacting Protein Kinase 1 (RIPK1) is implicated in various neurological disorders.
• Developing specific imaging agents for RIPK1 in the brain is crucial for research.
• Necroptosis, a regulated form of cell death, involves RIPK1.

Purpose of the Study:

• To develop and evaluate the first positron emission tomography (PET) radiotracer for imaging RIPK1 in the brain.
• To assess the efficacy of [18F]CNY-07 as a specific RIPK1 imaging agent in rodent models.

Main Methods:

• Synthesis of [18F]CNY-07 via copper-mediated 18F-radiolabeling.
• In vivo PET imaging studies in rodents.
• Blood-brain barrier penetration assessment.
• Self-blocking studies to determine binding specificity.

Main Results:

• [18F]CNY-07 successfully penetrated the blood-brain barrier in rodents.
• Maximum injected dose per unit volume in the brain reached 3% at 10 min post-injection.
• Self-blocking studies confirmed the specific binding of [18F]CNY-07 to RIPK1 in the brain, with a 30% reduction in radioactivity.

Conclusions:

• [18F]CNY-07 is a promising PET radioligand for brain RIPK1 imaging.
• This tracer can serve as a valuable research tool for investigating RIPK1-related neurological disorders.
• The development opens avenues for potential human diagnostic applications.